Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Garcia Weight Loss, Aesthetics & Hormone Therapy vs Royal Medical Center

vs+10
Royal Medical Center
Graded #492

Lower grade

The verdict

Garcia Weight Loss, Aesthetics & Hormone Therapy takes it — 59.4/100 to 49.4/100.

Garcia Weight Loss, Aesthetics & Hormone Therapy grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Established Tampa Bay medical weight-loss clinic operating since 2000 with four Florida locations.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGarcia Weight Loss, Aesthetics & Hormone Therapy +8
30
22
Dose & formulationGarcia Weight Loss, Aesthetics & Hormone Therapy +10
52
42
Clinical oversightGarcia Weight Loss, Aesthetics & Hormone Therapy +17
79
62
Labs & monitoringGarcia Weight Loss, Aesthetics & Hormone Therapy +11
97
86
FulfillmentGarcia Weight Loss, Aesthetics & Hormone Therapy +8
56
48
Contract termsEven
55
55
Garcia Weight Loss, Aesthetics & Hormone Therapy · left barRoyal Medical Center · right bar

The numbers

MetricGarcia Weight Loss, Aesthetics & Hormone TherapyRoyal Medical Center
WeighScore59.4/10049.4/100
GradeCC
Scorecard rank#342#492
Semaglutide$400/mo (starting dose, compounded)Not disclosed
TirzepatideNot disclosed$450/mo (2.5 mg dose, compounded)
Coverage1 stateCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only

Strengths

  • Established since 2000 with 4 Tampa Bay locations and 50,000+ patients treated
  • GLP-1 program includes full metabolic and hormone lab panel
  • Medication and supplies shipped directly to your door from partner pharmacy
  • Free 15-minute consultation; both weekly-visit (Premier) and monthly-visit (Standard) tiers
  • LegitScript transparency certification listed in footer

Where it loses points

  • Florida only — 4 locations in Tampa Bay metro area only
  • Pricing not publicly listed on website ($400/month per Facebook ad)
  • Specific GLP-1 drug (semaglutide vs tirzepatide) not disclosed on site
  • Telemedicine availability not confirmed on site despite Facebook ad claims
  • In-person visit model less convenient than fully online telehealth providers
Royal Medical Center

Graded #492 · C

Strengths

  • Physician founder Dr. Dagoberto Rodriguez, MD — Emory residency, former Coral Springs Medical Center chairman, U Miami faculty
  • Tirzepatide pricing fully itemized by dose tier ($450 / $650 / $800 / $1,100) — more transparent than 'starting at' floors
  • All-inclusive pricing bundles medication, supplies, injections, lab monitoring, and physician follow-ups
  • Broad catalog (HRT, TRT, peptides, ED, hair, vitamins) reflects an established multi-program clinic
  • Florida physician with 30+ years of practice — a strong physician-led care signal

Where it loses points

  • Operating legal entity not disclosed — only the 'Royal Medical Center' brand surfaced
  • Pharmacy partner not named — buyers can't verify licensure or 503A/503B status
  • No LegitScript badge displayed
  • States served not enumerated — site says 'nationwide' with no state list
  • Headline 'starting at $116/mo' conflicts with the actual $450/mo tirzepatide floor

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard